PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues – A population pharmacokinetic/pharmacodynamic analysis of rucaparib

Publisher: John Wiley & Sons Inc

E-ISSN: 2160-7648|4|2|89-98

ISSN: 2160-763X

Source: Clinical Pharmacology In Drug Development, Vol.4, Iss.2, 2015-03, pp. : 89-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content